PMC48 SETTING THE OPTIMAL SCREENING TOOLTHRESHOLD FOR A CHRONIC UNDERDIAGNOSED ILLNESS: WHOSE BURDEN MATTERS MOST?  by Yu, HT et al.
ciency among six distinct hybrid algorithms used with health care
data. METHODS: Six matching algorithms were examined. Each
combined covariate matching with a different propensity scoring
function: continuous factor, weighting factor, caliper, parenting
factor, nesting factor or partner. The algorithms were compared in
terms of 1:1 matching rate, computing time, bias balancing and
standardized difference. The inﬂuence of sample size variation on
stability and efﬁciency was considered. Paired T-test, Pearson
Chi-Square and Standardized Difference were adopted for assess-
ment. RESULTS: The superiority of some hybrid algorithms over
pure covariate matching was observed. In terms of matching rate,
the partner function reported the highest rate (99.7%), followed
by its function as a caliper (88.4%), while the parenting function
produced the lowest rate (59.5%). All others performed at a
similar level. Computing time varied, the most efﬁcient using the
propensity score as a parenting factor (00:25:10). The longest
reported times were seen when used as a weighting factor
(00:37:56) or caliper function (00:37:52). Differences are more
profound in large samples. In bias balancing tests, all algorithms
were balanced on categorical covariates except when the propen-
sity score was used as a partner or a caliper where each displayed
the lowest capability of producing p-values above 0.05. Signiﬁcant
reduction in standardized difference below 10% was indicative of
higher efﬁciency of the hybrid algorithms. Categorical covariates
produced values near zero despite the lower performance for the
partner approach. With increasing sample size, all investigations
performed as expected. CONCLUSION: Overall, these hybrid
applications exhibited greater efﬁciency in simultaneously over-
coming high dimensionality on covariate matching and reducing
variation in propensity score matching. Depending on data char-
acteristics and research proﬁles, each application has speciﬁc
merits in certain circumstances.
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Ankylosing spondylitis (AS) is a chronic disease with approxi-
mately 0.5% prevalence in the general population and 5%
among chronic back pain (CBP) sufferers. The disease typically
remains undiagnosed for over a decade which is problematic
since new treatments may alter the natural history. An AS screen-
ing instrument based upon patient reported data was developed
but selecting the optimal screening tool threshold is a critical
issue for discussion. Question items were identiﬁed from a litera-
ture review, patient focus groups, and an advisory board of
rheumatologists. A case-control study was conducted to test the
screening instrument among subjects with conﬁrmed AS (cases)
or CBP for3 months (controls). Question items were examined
in a multivariate logistic framework using best subsets modeling.
Receiver-operator characteristic analysis was conducted to deter-
mine optimal sensitivity (SE), speciﬁcity (SP), positive predictive
value (PPV), and negative predictive value (NPV) of the instru-
ment: AS prevalence set equal to 0.5% in the general population
and 5% among CBP sufferers. Responses from 102 cases and 214
controls were analyzed to develop a twelve-variable model. Sen-
sitivities ranging from 69.6% to 90.2% were associated with
speciﬁcities of 99.1% to 79.9%, respectively. Lowering sensitivi-
ties reduced the portion of false positives seen by the provider
from 95% to 20.3% (78.6% reduction) and 99.5% to 72.8%
(26.8% reduction) for the CBP and general populations, respec-
tively (SE = 69.6%, SP = 99.1%). Selecting the optimal screening
tool threshold depends on whose burden matters the most:
increasing sensitivity of the instrument would increase the prob-
ability of identifying patients with disease earlier and the ability
to improve AS patient well-being. However, this approach would
increase the economic burden (additional medical evaluations)
from the payer perspective, raise the patient care burden from the
rheumatologist perspective, and reduce quality of life for those
with false positives. We will discuss the trade-offs in this real
world example.
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Ignoring heterogeneity in health may bias measurement of
intervention outcomes through confounding with intervention
of interest. If repeated observations on each subject are avail-
able, heterogeneity may be usefully included in outcomes
studies. We assume heterogeneous health status as a latent
index and multiple health proxies (and their correlations) are
used to estimate heterogeneous health grouping from the latent
index. For example, in a treatment effect study with longitudi-
nal data: 1) estimate K, the number of heterogeneous groups,
by latent class cluster analysis (LCCA) using health proxies of
each subject at each period, such as comorbidity indices, length
of hospitalization, total health care cost and so on; 2) if K > 1
(heterogeneity), estimate a treatment effect for each group and
compare the results across the groups; 3) if the effects vary over
the groups, heterogeneity can be translated by each group’s
health proﬁle (e.g. higher effectiveness found in sick but less
hospitalized group). This approach is relatively conservative
and combines multiple proxies objectively. Estimating K implies
a near consensus of model selection criteria such as Bayesian
Information Criteria (BIC), adjusted BIC, Akaike Information
Criteria (AIC), and consistent AIC; and bootstrap likelihood
ratio test (BLRT). Furthermore, it is difﬁcult to ﬁnd a practi-
cally useful K (say <5) because K tends to diverge to N (i.e.
each subject is a group), for a large enough sample size N.
Applying heterogeneity estimation to a claims data of 3260
subjects for two years found two heterogeneous groups (BIC,
adjusted BIC, consistent AIC, and BLRT all supported K = 2
except AIC). One group (N = 2841) was signiﬁcantly sicker
than the other group (N = 419) in Year 1 (and in Year 2) at
5%: Charlson Comorbidity Index 3.91 vs 0.11 (4.49 vs 0.14);
length of stay 0.87 vs 0.03 (1.04 vs 0); total cost $10690 vs
$245 ($11149 vs $184).
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Develop a quantitative and practical methodology to structure,
objectify and facilitate health care decisionmaking. A concep-
tual framework was developed that segregated components of
decision-making into three categories: 1) quality of evidence
available; 2) intrinsic value of the health care intervention; and 3)
extrinsic or system related value, usually not directly quantiﬁ-
able. Using this framework, practical tools to assess health care
interventions were designed drawing on an extensive review of
the literature and of current decisionmaking processes for drug
reimbursement around the world. A matrix to quantify the
quality of evidence available for a health care intervention was
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